<DOC>
	<DOCNO>NCT00415558</DOCNO>
	<brief_summary>The purpose prospective , single-arm , un-blinded , multi-site clinical study ass safety efficacy Microwave Ablation System treatment symptomatic paroxysmal atrial fibrillation ( PAF ) minimally invasive surgical ( MIS ) procedure approximately 30 patient 6 investigational site United States .</brief_summary>
	<brief_title>Prospective Clinical Study Guidant Microwave Ablation System Treatment PAF MIS Procedure</brief_title>
	<detailed_description>The study population study comprise patient diagnose symptomatic ( PAF ) least 6 month prior study entry . Patients qualify study meet stringent inclusion/exclusion criterion , sign informed consent agree return followup visit 1 , 3 , 6 , 9 12 month . All study patient receive microwave ablation treat symptomatic PAF . The Microwave Ablation System use MIS procedure beat heart order ablate specify lesion pattern .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient great = 18 year age Patient document symptomatic paroxysmal atrial fibrillation ( PAF ) refractory least 1 antiarrhythmic ( Class IA , IC , III ) drug . Patient episodes symptomatic AF include , limited , palpitation , lightheadedness , fatigue , dyspnea , and/or chest pain . A minimum 6month history symptomatic paroxysmal AF ( document patient report medical record ) . A minimum 2 discrete symptomatic paroxysmal AF episodes month prior study entry . Paroxysmal AF rhythm must document objective evidence ( 12lead electrocardiogram [ ECG ] , Holter monitor , event monitor , telemetry rhythm strip ) presence sinus rhythm and/or underlie rhythm episode . Patient inform nature study , agree provision , provide write informed consent . Patient cerebral vascular accident transient ischemic attack within previous 6 month . Patient myocardial infarction within previous 6 week . Patient underlie metabolic etiology relate AF ( e.g. , hyperthyroidism , metabolic disorder ) . Patient significant underlying structural heart disease ( e.g. , valvular disease , presence aneurysm , leave ventricular hypertrophy ) require surgical procedural intervention . Patient prior catheter ablation procedure treatment AF within previous 6 month . Patient evidence , history , 50 % stenosis pulmonary vein . Patient previous thoracic procedure result sternal opening and/or pericardial opening ( e.g. , surgical ablation , coronary artery bypass graft [ CABG ] , valve repair ) . Patient leave atrial size &gt; 6.0 cm measure echocardiogram . Patient leave ventricular ejection fraction ( LVEF ) &lt; 35 % . Patient require treatment CAD ( coronary artery disease ) untreated unstable angina . Patient presence esophageal fistula esophageal stricture , untreated esophagitis , varix , dysphagia , odynophagia cause anatomical abnormality disease contraindicate transesophageal echocardiography . Patient severe chronic obstructive pulmonary disease . Patient know allergy contraindication Coumadin ( warfarin ) therapy , inability comply Coumadin ( warfarin ) therapy . Patient know allergy contraindication comply antiarrhythmic ( Class IA , IC , III ) therapy . Patient acute illness active systemic infection sepsis . Patient comorbidity life expectancy le one year protocol noncompliance would limit followup . Patient geographically remote and/or unable return followup examination . Patient pregnant planning become pregnant study . Patient enrol concurrent study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Atrial Fibrillation</keyword>
</DOC>